A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [C-11]erlotinib and [F-18]afatinib in lung cancer-bearing mice

P. Slobbe, A.D. Windhorst, M. Stigter-van Walsum, E.F. Smit, H.G. Niessen, F. Solca, G Stehle, G.A.M.S. van Dongen, A.J. Poot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article number14
JournalEJNMMI Research
Volume5
DOIs
Publication statusPublished - 2015

Cite this